-transparent.png){kind=logo}
In animals with a ligated anterior descending left coronary artery, a single administration of nonaclazine (5 mg/kg bw) leads to a marked increase in the coronary blood flow and to an improvement in cardiovascular system function. Administration of nonachlazin for 7 days helps normalize the electrophysiological and hemodynamic characteristics and produces a beneficial effect on the myocardial blood flow and contractility. Interaction of nonaclazine with adrenergic receptors does not appear to have any decisive significance in the drug action mode.
Related Publications
N M Oganesian, and
S S Oganesian, and
M A Varosian, and
I G Bagramian, and
S B Barinian
January 1985,
Farmakologiia i toksikologiia,
N M Oganesian, and
S S Oganesian, and
M A Varosian, and
I G Bagramian, and
S B Barinian
January 1976,
Farmakologiia i toksikologiia,
N M Oganesian, and
S S Oganesian, and
M A Varosian, and
I G Bagramian, and
S B Barinian
January 1981,
Folia medica Cracoviensia,
N M Oganesian, and
S S Oganesian, and
M A Varosian, and
I G Bagramian, and
S B Barinian
January 1979,
Farmakologiia i toksikologiia,
N M Oganesian, and
S S Oganesian, and
M A Varosian, and
I G Bagramian, and
S B Barinian
January 1979,
Farmakologiia i toksikologiia,
N M Oganesian, and
S S Oganesian, and
M A Varosian, and
I G Bagramian, and
S B Barinian
January 1986,
Farmakologiia i toksikologiia,
N M Oganesian, and
S S Oganesian, and
M A Varosian, and
I G Bagramian, and
S B Barinian
January 1983,
Advances in myocardiology,
N M Oganesian, and
S S Oganesian, and
M A Varosian, and
I G Bagramian, and
S B Barinian
January 1976,
Farmatsiia,
N M Oganesian, and
S S Oganesian, and
M A Varosian, and
I G Bagramian, and
S B Barinian
January 1978,
Farmatsiia,
N M Oganesian, and
S S Oganesian, and
M A Varosian, and
I G Bagramian, and
S B Barinian
January 1976,
Farmatsiia,
